# Bridging Causal Inference and Real-World Evidence: A Study of FDA and Other Regulatory Guidelines
인과추론과 Real World Evidence (RWE) 가이드라인을 공부합니다. 자료는 깃허브 페이지 형태로 공유할 계획입니다.

아래는 깃허브 페이지 링크입니다.
https://pseudo-lab.github.io/Bridging-Causal-Inference-and-Real-World-Evidence-A-Study-of-FDA-and-Other-Regulatory-Guidelines/intro.html

## 주차별 목표와 학습 내용
💡 주차별 진행계획은 러너(스터디원)분들과 협의에 의해 변경될 수 있습니다.

| 날짜 | 내용 | 발표자 | 매체 | 
| ----- | ----- | -------- | ----- |
| 2024/09/25 | OT (스터디 소개, 방향 논의, Ice breaking) | [박상호]() | [링크]() | 
| 2024/10/02 | Causal inference chapter 1 ~ 2  | [박상호]() | [링크](https://causalinferencelab.github.io/Causal-Inference-with-Python/landing-page.html) | 
| 2024/10/16 | Causal inference chapter 3 ~ 4  | [박상호]() | [링크](https://causalinferencelab.github.io/Causal-Inference-with-Python/landing-page.html) | 
| 2024/10/23 | FRAMEWORK FOR FDA’S REAL-WORLD EVIDENCE PROGRAM | [박상호]() | [링크](https://www.fda.gov/media/120060/download?attachment) | 
| 2024/10/30 | FRAMEWORK FOR FDA’S REAL-WORLD EVIDENCE PROGRAM | [박상호]() | [링크](https://www.fda.gov/media/120060/download?attachment) | 
| 2024/11/06 | General Principles on Plan, Design and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines (ICH M14 guideline) | [박상호]() | [링크](https://database.ich.org/sites/default/files/ICH_M14_Step3_DraftGuideline_2024_0521.pdf) | 
| 2024/11/13 | General Principles on Plan, Design and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines (ICH M14 guideline) | [박상호]() | [링크](https://database.ich.org/sites/default/files/ICH_M14_Step3_DraftGuideline_2024_0521.pdf) | 
| 2024/11/20 | Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline [RWE Reflection paper - draft for public consultation (europa.eu)] | [박상호]() | [링크](https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-real-world-data-non-interventional-studies-generate-real-world-evidence_en.pdf) | 
| 2024/11/27 | MHRA guideline on RCT using RWD to support regulatory decisions | [박상호]() | [링크](https://www.gov.uk/government/publications/mhra-guidance-on-the-use-of-real-world-data-in-clinical-studies-to-support-regulatory-decisions/mhra-guideline-on-randomised-controlled-trials-using-real-world-data-to-support-regulatory-decisions) | 
| 2024/12/04 | Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry | [박상호]() | [링크](https://www.fda.gov/media/171667/download) | 
| 2024/12/11 | Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products Guidance for Industry | [박상호]() | [링크](https://www.fda.gov/media/177128/download) | 
| 2024/12/18 | Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices Guidance for Industry and Food and Drug Administration Staff | [박상호]() | [링크](https://www.fda.gov/media/99447/download) | 
| 2025/01/08 | 의료기기의 실사용증거 적용에 대한 가이드라인 (식약처) | [박상호]() | [링크](https://www.mfds.go.kr/brd/m_1060/view.do?seq=14328)| 
| 2025/01/15 | 의료기기의 실사용증거 적용에 대한 가이드라인 (식약처) | [박상호]() | [링크](https://www.mfds.go.kr/brd/m_1060/view.do?seq=14328)| 
| 2025/01/22 | Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry | [박상호]() | [링크](https://www.fda.gov/media/152503/download) | 
| 2025/01/29 | Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry | [박상호]() | [링크](https://www.fda.gov/media/152503/download) | 
